guabenxan 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antihypertensives, guanidine derivatives 1332 19889-45-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • guabenxan sulfate
  • tensigradyl
  • guabenxan
  • guabenzodioxan
combination of bemetizid diuretic & guabenxan antihypertensive agent
  • Molecular weight: 207.23
  • Formula: C10H13N3O2
  • CLOGP: 0.35
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 3
  • TPSA: 80.36
  • ALOGS: -2.36
  • ROTB: 2

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use (View source of the data)

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 10.06 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
C0617438 UMLSCUI
CHEBI:134872 CHEBI
CHEMBL2105111 ChEMBL_ID
28563 PUBCHEM_CID
3544 INN_ID
C036327 MESH_SUPPLEMENTAL_RECORD_UI
C036328 MESH_SUPPLEMENTAL_RECORD_UI
SAW16W26X6 UNII

Pharmaceutical products:

None